These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 28653770)

  • 1. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
    Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
    Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
    Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
    Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-investigation of the concordance of human NAT2 phenotypes and genotypes.
    Bolt HM; Selinski S; Dannappel D; Blaszkewicz M; Golka K
    Arch Toxicol; 2005 Apr; 79(4):196-200. PubMed ID: 15558239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance between the deduced acetylation status generated by high-speed: real-time PCR based NAT2 genotyping of seven single nucleotide polymorphisms and human NAT2 phenotypes determined by a caffeine assay.
    Rihs HP; John A; Scherenberg M; Seidel A; Brüning T
    Clin Chim Acta; 2007 Feb; 376(1-2):240-3. PubMed ID: 17011540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis.
    Woolhouse NM; Qureshi MM; Bastaki SM; Patel M; Abdulrazzaq Y; Bayoumi RA
    Pharmacogenetics; 1997 Feb; 7(1):73-82. PubMed ID: 9110365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatotoxicity in Tunisian patients with tuberculosis.
    Ben Mahmoud L; Ghozzi H; Kamoun A; Hakim A; Hachicha H; Hammami S; Sahnoun Z; Zalila N; Makni H; Zeghal K
    Pathol Biol (Paris); 2012 Oct; 60(5):324-30. PubMed ID: 21856096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis.
    Suvichapanich S; Fukunaga K; Zahroh H; Mushiroda T; Mahasirimongkol S; Toyo-Oka L; Chaikledkaew U; Jittikoon J; Yuliwulandari R; Yanai H; Wattanapokayakit S; Tokunaga K
    Pharmacogenet Genomics; 2018 Jul; 28(7):167-176. PubMed ID: 29781872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetyltransferase 2 polymorphism and acetylation profiles in Buginese ethnics of Indonesia.
    Yuliwulandari R; Susilowati RW; Razari I; Viyati K; Umniyati H; Prayuni K
    Ann Hum Genet; 2019 Nov; 83(6):465-471. PubMed ID: 31332782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of cytochrome P450-1A2 (CYP1A2) among Emiratis.
    Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki SMA
    PLoS One; 2017; 12(9):e0183424. PubMed ID: 28934216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of NAT2 gene polymorphisms in an Indian population: association with plasma isoniazid concentration in a cohort of tuberculosis patients.
    Singh N; Dubey S; Chinnaraj S; Golani A; Maitra A
    Mol Diagn Ther; 2009; 13(1):49-58. PubMed ID: 19351215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population.
    Djordjevic N; Carrillo JA; Ueda N; Gervasini G; Fukasawa T; Suda A; Jankovic S; Aklillu E
    J Clin Pharmacol; 2011 Jul; 51(7):994-1003. PubMed ID: 20801937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.
    Cascorbi I; Drakoulis N; Brockmöller J; Maurer A; Sperling K; Roots I
    Am J Hum Genet; 1995 Sep; 57(3):581-92. PubMed ID: 7668286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and concordance of N-acetyltransferase genotype and phenotype in an American population.
    Gross M; Kruisselbrink T; Anderson K; Lang N; McGovern P; Delongchamp R; Kadlubar F
    Cancer Epidemiol Biomarkers Prev; 1999 Aug; 8(8):683-92. PubMed ID: 10744128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergy.
    Schnuch A; Westphal GA; Müller MM; Schulz TG; Geier J; Brasch J; Merk HF; Kawakubo Y; Richter G; Koch P; Fuchs T; Gutgesell T; Reich K; Gebhardt M; Becker D; Grabbe J; Szliska C; Aberer W; Hallier E
    Contact Dermatitis; 1998 Apr; 38(4):209-11. PubMed ID: 9565293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism.
    Okumura K; Kita T; Chikazawa S; Komada F; Iwakawa S; Tanigawara Y
    Clin Pharmacol Ther; 1997 May; 61(5):509-17. PubMed ID: 9164413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects.
    Brocvielle H; Muret P; Goydadin AC; Boone P; Broly F; Kantelip JP; Humbert P
    Skin Pharmacol Appl Skin Physiol; 2003; 16(6):386-92. PubMed ID: 14528063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking, N-acetyltransferase 2 polymorphisms and systemic lupus erythematosus in a Japanese population.
    Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Takahashi H; Kobashi G;
    Lupus; 2009 Jun; 18(7):630-8. PubMed ID: 19433464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of N-acetyltransferase 2 genetic polymorphism on 4,4'-methylenebis(2-chloroaniline)-induced genotoxicity and oxidative stress.
    Habil MR; Salazar-González RA; Doll MA; Hein DW
    Arch Toxicol; 2023 Jun; 97(6):1773-1781. PubMed ID: 37142755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
    Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA
    Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
    Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES
    Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.